ペプチドリームの株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2023/02/17 | 1,898 | 1,911 | 1,837 | 1,887 | -47 | -2.4% | 1,667,900 |
2023/02/16 | 1,894 | 1,966 | 1,894 | 1,934 | +54 | +2.9% | 1,263,000 |
2023/02/15 | 1,960 | 1,992 | 1,875 | 1,880 | -206 | -9.9% | 2,698,200 |
2023/02/14 | 2,071 | 2,098 | 2,063 | 2,086 | +9 | +0.4% | 672,900 |
2023/02/13 | 2,045 | 2,091 | 2,041 | 2,077 | +14 | +0.7% | 467,200 |
2023/02/10 | 2,106 | 2,106 | 2,041 | 2,063 | -44 | -2.1% | 889,800 |
2023/02/09 | 2,040 | 2,117 | 2,037 | 2,107 | +42 | +2% | 913,800 |
2023/02/08 | 2,035 | 2,069 | 2,000 | 2,065 | +38 | +1.9% | 910,400 |
2023/02/07 | 2,011 | 2,058 | 2,007 | 2,027 | +27 | +1.4% | 991,700 |
2023/02/06 | 2,020 | 2,041 | 1,993 | 2,000 | +2 | +0.1% | 588,300 |
2023/02/03 | 2,020 | 2,029 | 1,990 | 1,998 | +5 | +0.3% | 482,600 |
2023/02/02 | 1,983 | 2,003 | 1,954 | 1,993 | +20 | +1% | 638,000 |
2023/02/01 | 2,016 | 2,026 | 1,971 | 1,973 | -35 | -1.7% | 1,024,300 |
2023/01/31 | 2,009 | 2,039 | 1,997 | 2,008 | -16 | -0.8% | 618,200 |
2023/01/30 | 2,046 | 2,058 | 2,010 | 2,024 | -9 | -0.4% | 620,400 |
2023/01/27 | 2,065 | 2,065 | 2,023 | 2,033 | -42 | -2% | 737,900 |
2023/01/26 | 2,088 | 2,120 | 2,055 | 2,075 | +6 | +0.3% | 917,300 |
2023/01/25 | 2,060 | 2,081 | 2,022 | 2,069 | -23 | -1.1% | 1,258,200 |
2023/01/24 | 2,069 | 2,146 | 2,060 | 2,092 | +60 | +3% | 1,769,500 |
2023/01/23 | 2,034 | 2,069 | 2,025 | 2,032 | +7 | +0.3% | 899,200 |
2023/01/20 | 1,994 | 2,038 | 1,983 | 2,025 | -5 | -0.2% | 1,215,100 |
2023/01/19 | 2,150 | 2,172 | 2,014 | 2,030 | -20 | -1% | 3,804,300 |
2023/01/18 | 2,020 | 2,061 | 1,984 | 2,050 | +44 | +2.2% | 1,250,600 |
2023/01/17 | 2,049 | 2,062 | 1,972 | 2,006 | -23 | -1.1% | 713,300 |
2023/01/16 | 2,036 | 2,070 | 2,007 | 2,029 | -16 | -0.8% | 769,000 |
2023/01/13 | 2,040 | 2,070 | 2,032 | 2,045 | -19 | -0.9% | 764,000 |
2023/01/12 | 2,057 | 2,093 | 2,038 | 2,064 | +14 | +0.7% | 820,000 |
2023/01/11 | 1,984 | 2,061 | 1,973 | 2,050 | +67 | +3.4% | 1,110,100 |
2023/01/10 | 1,985 | 2,010 | 1,944 | 1,983 | -39 | -1.9% | 1,658,800 |
2023/01/06 | 1,993 | 2,067 | 1,984 | 2,022 | +12 | +0.6% | 1,580,600 |
2023/01/05 | 2,035 | 2,036 | 1,957 | 2,010 | +15 | +0.8% | 1,505,300 |
2023/01/04 | 2,055 | 2,059 | 1,968 | 1,995 | -82 | -3.9% | 2,078,600 |
2022/12/30 | 1,985 | 2,133 | 1,973 | 2,077 | +110 | +5.6% | 3,113,400 |
2022/12/29 | 1,915 | 1,967 | 1,880 | 1,967 | +12 | +0.6% | 1,778,200 |
2022/12/28 | 1,988 | 2,020 | 1,902 | 1,955 | -10 | -0.5% | 4,053,100 |
2022/12/27 | 1,795 | 1,986 | 1,773 | 1,965 | +328 | +20% | 5,561,900 |
2022/12/26 | 1,686 | 1,686 | 1,622 | 1,637 | -49 | -2.9% | 718,600 |
2022/12/23 | 1,614 | 1,711 | 1,608 | 1,686 | +49 | +3% | 1,160,100 |
2022/12/22 | 1,670 | 1,670 | 1,567 | 1,637 | +95 | +6.2% | 1,534,200 |
2022/12/21 | 1,580 | 1,594 | 1,525 | 1,542 | -36 | -2.3% | 835,100 |
2022/12/20 | 1,589 | 1,610 | 1,554 | 1,578 | -18 | -1.1% | 967,400 |
2022/12/19 | 1,643 | 1,643 | 1,596 | 1,596 | -79 | -4.7% | 810,100 |
2022/12/16 | 1,683 | 1,702 | 1,652 | 1,675 | -70 | -4% | 1,112,100 |
2022/12/15 | 1,718 | 1,770 | 1,714 | 1,745 | +28 | +1.6% | 1,064,900 |
2022/12/14 | 1,730 | 1,753 | 1,706 | 1,717 | +38 | +2.3% | 934,200 |
2022/12/13 | 1,745 | 1,762 | 1,662 | 1,679 | -13 | -0.8% | 1,021,800 |
2022/12/12 | 1,629 | 1,700 | 1,624 | 1,692 | +45 | +2.7% | 1,084,100 |
2022/12/09 | 1,600 | 1,654 | 1,598 | 1,647 | +82 | +5.2% | 1,077,500 |
2022/12/08 | 1,570 | 1,587 | 1,545 | 1,565 | +9 | +0.6% | 832,000 |
2022/12/07 | 1,550 | 1,592 | 1,544 | 1,556 | -22 | -1.4% | 911,100 |
551~
600
件表示中 / 2918件
類似銘柄と比較する
現在ご覧いただいている「ペプチド」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
ペプチド | 171,800円 | +5.0% | +1.5% | 0.00% | 14.70倍 | 3.91倍 |
|
東大発のペプチド創薬ベンチャーの雄。海外製薬大手との提携多数。買収で放射性医薬品に参入 |
日本新薬 | 341,500円 | +8.0% | -15.3% | 3.63% | 9.59倍 | 0.93倍 |
|
医家向け医薬品主体、自社創薬は泌尿器科、血液内科、難病・希少疾患に集中。機能食品も育成 |
サンバイオ | 331,000円 | - | - | 0.00% | - | 153.31倍 |
|
脳疾患向け再生細胞薬の開発・製造・販売目指すバイオベンチャー。米国で創業し日本に逆上陸 |
サワイGHD | 176,100円 | +5.9% | +24.5% | 3.12% | 11.68倍 | 1.10倍 |
|
ジェネリック(後発)薬大手メーカー。21年春に沢井製薬が持株会社化。大型買収で米国本格展開 |
キッセイ薬 | 389,000円 | +3.6% | +6.1% | 3.08% | 13.10倍 | 0.77倍 |
|
医薬品中堅。泌尿器、腎・透析、未充足医療が重点領域。主軸特許切れ、新しい柱育成。海外は導出 |
市場注目の銘柄
チャート関連のコラム